Back to top of page

Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)

Required information for the Can-ACT grant application:

​

1. Research Project Description: Provide a detailed description of the proposed research project, including the aim, objectives, and significance of the study.

​

2. Research Plan: Outline the specific research plan, including study design, methodology, and experimental procedures.

​

3. Collaborative Approach: Describe the collaborative approach to preclinical testing and translational studies, highlighting how the multi-investigator team will work together to bring new cell therapy products to the clinic.

​

4. Expertise and Qualifications: Provide information on the expertise and qualifications of the multi-investigator team members, including their relevant experience in cellular therapy and pediatric oncology.

​

5. Budget and Justification: Present a detailed budget for the proposed research project, including funding requested for personnel, supplies, equipment, and other expenses. Justify the requested budget based on the needs of the study.

​

6. Timeline and Milestones: Outline a timeline for the proposed research project, including key milestones and expected completion dates for each phase of the study.

​

7. Evaluation and Outcome Measures: Describe the evaluation and outcome measures that will be used to assess the success and impact of the proposed research project.

​

8. Institutional Support: Provide information on the support and resources available at the applicant institution to carry out the proposed research project.

​

9. Ethical Considerations: Discuss the ethical considerations related to the proposed research project, including informed consent, protection of human subjects, and compliance with relevant regulations and guidelines.

​

10. Dissemination Plan: Outline a plan for disseminating the results of the research project, including publication in scientific journals, presentations at conferences, and sharing of data and resources.

​

11. Project Team: Provide a list of the project team members, their roles, and their institutional affiliations.

​

12. Data Management and Analysis: Describe the proposed data management and analysis plan, including how the collected data will be stored, analyzed, and reported.

​

13. Regulatory Approvals: Indicate any regulatory approvals that will be required for the proposed research project, such as Institutional Review Board (IRB) approval or Investigational New Drug (IND) application.

​

14. Potential Risks and Mitigation Strategies: Identify potential risks and challenges associated with the proposed research project and provide strategies for mitigating these risks.

​

15. Letter of Support: Include letters of support from collaborating institutions and individuals, highlighting their commitment to the project and their role in its success.

​

16. References: Provide a list of references cited in the

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows